Journal
BIOMEDICAL CHROMATOGRAPHY
Volume 35, Issue 10, Pages -Publisher
WILEY
DOI: 10.1002/bmc.5180
Keywords
antimicrobial activity; Escherichia coli; metabolomics; proteomics; simvastatin
Ask authors/readers for more resources
The study focused on the altered biological and metabolic processes induced by simvastatin at protein and metabolite levels. Proteomics results showed induction of various antimicrobial targets, while metabolomics results revealed phenotypic changes in cells under simvastatin stress. Integrated proteomics and metabolomics results indicated alterations in various metabolic processes in response to stress conditions.
Globally, simvastatin is one of the most commonly used statin drugs. Its antimicrobial properties have been investigated against various pathogens. However, its effect on biological processes in bacteria has been unclear. This study focused on altered biological and metabolic processes at protein and metabolite levels induced by simvastatin. MS-based proteomics and metabolomics were used to investigate the altered proteins and metabolites between experimental groups. Proteomics results showed that simvastatin induced various antimicrobial targets such as chaperon protein DnaK and cell division protein FtsZ. Metabolomics results revealed phenotypic changes in cells under simvastatin stress. Integrated proteomics and metabolomics result indicated that various metabolic processes were altered to adapt to stress conditions. Energy metabolism (glycolysis, tricarboxylic acid cycle, etc.), amino acid synthesis and ribosomal proteins, and purine and pyrimidine synthesis were induced by the effect of simvastatin. This study will contribute to the understanding of antimicrobial properties of statin drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available